AIRFLUSAL MDI is a prescription medication used in the management and treatment of asthma and chronic obstructive pulmonary disease (COPD). It is a Metered Dose Inhaler (MDI) that delivers a specific amount of medication directly to the lungs, providing relief from symptoms such as wheezing, shortness of breath, and tightness in the chest. AIRFLUSAL MDI typically contains a combination of two active ingredients: a corticosteroid, which reduces inflammation in the airways, and a long-acting beta-agonist, which helps to relax the muscles around the airways and makes breathing easier. This dual-action approach helps to prevent asthma attacks and improve lung function over time. Patients are advised to use AIRFLUSAL MDI regularly as prescribed by their healthcare provider to achieve the best results in managing their respiratory condition.